Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Radha Gopalan
Study ID
NCT05816265
Phase
PHASE4
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • IV Iron Infusion Group — DRUG
    Subjects will receive IV Iron Infusion. Dosage of iron will be at discretion of physicians

Study Details

Patients with heart failure with reduced ejection fraction and iron deficiency will be randomized to either receive iron infusion or be in the control group. The study is looking at how iron replacement affects exercise capacity as measured by peak oxygen uptake.

Key Dates

Start date
Jan 24, 2024
Status verified
Apr 2025
Primary completion
Mar 31, 2026
Completion
Mar 31, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: IV Iron Infusion Group
    Subjects will receive iron infusion 1 week after enrollment. Dosage of iron will be at discretion of physicians
  • No Intervention: Control Group
    Subjects will not receive iron replacement infusion.

Primary Outcome Measure

Exercise Capacity [ Time Frame: 2 months after IV iron infusion ]

Locations (1)

FacilityCityStateZIPSite coordinators
Banner - University Medical Center, Phoenix campusPhoenixArizona85006-

Find similar trials in Phoenix, AZ

By condition
Heart failure
By specialty
CardiologyHeart disease
By research site
Banner - University Medical Center, Phoenix campus· Phoenix, AZ

Related Studies